CAS 1661839-45-7

CCT251545

CAS: 1661839-45-7

CCT251545 is an potent and oral-bioavailable WNT signaling inhibitor(IC50 of 5 nM in 7dF3 cells).

Formel: C₂₃H₂₄ClN₅O

Reinheit: 98.29% - 98.69%

Farbe und Form: White Solid

Molekulargewicht: 421.92

Ref: TM-T14907

2,8-Diazaspiro[4.5]decan-1-one, 8-[3-chloro-5-[4-(1-methyl-1H-pyrazol-4-yl)phenyl]-4-pyridinyl]-

CAS: 1661839-45-7

Formel: C₂₃H₂₄ClN₅O

Reinheit: %

Farbe und Form: Solid

Molekulargewicht: 421.9226

Ref: IN-DA001WJ4

CCT251545

CAS: 1661839-45-7

CCT251545

Formel: C₂₃H₂₄ClN₅O

Reinheit: ≥98%

Molekulargewicht: 421.92

Ref: 54-BUP04203

CCT251545

CAS: 1661839-45-7

8-(3-Chloro-5-(4-(1-methyl-1H-pyrazol-4-yl)phenyl)pyridin-4-yl)-2,8-diazaspiro[4.5]decan-1-one

Formel: C₂₃H₂₄ClN₅O

Reinheit: 98+%

Molekulargewicht: 421.92

Ref: IN-DG630423

CCT251545

CAS: 1661839-45-7

CCT251545 is a small molecule that inhibits the Wnt signaling pathway by binding to β-catenin. This drug may be used for the treatment of inflammatory bowel disease and other autoimmune diseases. The molecular structure of CCT251545 is still unknown but it has been shown to bind to the DNA binding proteins, which are important for gene expression. CCT251545 can also be used as a crystallography probe in X-ray crystallography experiments.

Formel: C₂₃H₂₄ClN₅O

Reinheit: Min. 95%

Molekulargewicht: 421.92 g/mol

Ref: 3D-LRC83945